59 Avsnitt

  1. The state of psychedelics: Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)

    Publicerades: 2022-06-05

  2. Empowering the next wave of psychedelic therapists: Journey Clinical

    Publicerades: 2022-05-23

  3. Osmind and the future of electronic health records in psychedelic medicine

    Publicerades: 2022-04-18

  4. Palo Santo on investing in 2nd gen psychedelics and public markets

    Publicerades: 2022-03-21

  5. Designing psychedelic mindstates, with Mindstate Design Labs

    Publicerades: 2022-02-10

  6. PsyMed Ventures, our venture fund to invest in psychedelic medicine & mental health tech

    Publicerades: 2022-01-10

  7. MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy

    Publicerades: 2021-11-24

  8. On transformational ketamine therapy and running an integrative psychedelic clinic

    Publicerades: 2021-10-28

  9. The new frontiers of DMT therapies

    Publicerades: 2021-10-06

  10. Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde

    Publicerades: 2021-08-13

  11. Analyzing the atai Life Sciences IPO

    Publicerades: 2021-06-10

  12. A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx

    Publicerades: 2021-05-04

  13. Clinical trials, media, reciprocity, open science: Founder of The Trip Report, Zach Haigney

    Publicerades: 2021-03-16

  14. How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka

    Publicerades: 2021-02-24

  15. From serving medicine to company founder: NANA founder Flor Bollini

    Publicerades: 2021-01-05

  16. Helping psychedelic practitioners through software: Maya Health CEO David Champion

    Publicerades: 2020-10-19

  17. How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer

    Publicerades: 2020-09-17

  18. Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin

    Publicerades: 2020-08-13

  19. Dylan Beynon: ketamine-assisted therapy for anxiety and depression

    Publicerades: 2020-06-21

3 / 3

Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more. 

Visit the podcast's native language site